Cronos Group Inc. logo

Cronos Group Inc. (CRON)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
2. 49
0
0%
$
949.79M Market Cap
- P/E Ratio
0% Div Yield
1,299,106 Volume
- Eps
$ 2.49
Previous Close
Day Range
2.48 2.52
Year Range
1.6 3.16
Want to track CRON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 80 days

Summary

CRON closed Friday higher at $2.49, an increase of 0% from Thursday's close, completing a monthly increase of 1.63% or $0.04. Over the past 12 months, CRON stock gained 23.88%.
CRON is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

CRON Chart

Similar

Ani Pharmaceuticals Inc.
$ 81.77
-1.17%
Phibro Animal Health Corporation
$ 39.16
-3.95%
Alvotech S.A.
$ 5.47
+7.89%
Harrow Inc.
$ 45.75
-2.18%
Alvotech S.A.
$ 0.65
+0.02%
Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling

Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling

The congressional funding bill included a THC cap that effectively bans most hemp products, a move industry leaders say threatens the $28 billion market. More than 300,000 jobs are at risk, with economic impacts expected in states with large hemp sectors, including Kentucky, Texas and Utah, industry experts said.

Cnbc | 3 weeks ago
Bitcoin, Ethereum, XRP, Cronos Gain. 2 Ways Trump Is Boosting Cryptos.

Bitcoin, Ethereum, XRP, Cronos Gain. 2 Ways Trump Is Boosting Cryptos.

Bitcoin, Ethereum and other cryptocurrencies were reacting to hopes of interest-rate cuts while President Donald Trump's family is backing smaller crypto Cronos.

Barrons | 3 months ago
Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling

Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling

Cannabis stocks rallied today over news of possible rescheduling by the Trump administration. Even though Cronos Group Inc. does not have a U.S. entry strategy, its stock price was up 15% on the news. Cronos reported improved financial performance last Thursday with higher revenues and improved international sales.

Seekingalpha | 3 months ago

Cronos Group Inc. (CRON) FAQ

What is the stock price today?

The current price is $2.49.

On which exchange is it traded?

Cronos Group Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is CRON.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 949.79M.

What is the earnings per share?

The EPS is 0.01.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Cronos Group Inc. ever had a stock split?

No, there has never been a stock split.

Cronos Group Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Michael Ryan Gorenstein CEO
NASDAQ (NMS) Exchange
22717L101 CUSIP
CA Country
459 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Cronos Group Inc. stands as a pioneering entity in the cannabinoid industry, dedicating its efforts to the cultivation, production, and distribution of cannabis products across notable markets in Canada, Israel, and Germany. Since its establishment in 2012, the company has positioned itself in Toronto, Canada, navigating the complexities of the ever-evolving cannabis landscape. Through strategic brand development and an unwavering commitment to quality, Cronos Group has carved a niche for itself, becoming synonymous with excellence in the realm of cannabinoid offerings.

Products and Services

  • Dried Flower: Cronos Group offers a variety of premium dried cannabis flowers, catering to the traditional cannabis consumer. These products are carefully cultivated to ensure the highest quality and potency, meeting the diverse preferences and needs of their clientele.
  • Pre-rolls: For those seeking convenience without compromising on quality, Cronos Group's pre-rolled cannabis offers an easy-to-use option. Expertly rolled from their top-quality dried flower, these pre-rolls provide a consistent and satisfying experience for both new and seasoned users.
  • Oils: Cannabis oils by Cronos Group are extracted using state-of-the-art techniques to ensure purity and potency. These oils are versatile, designed for consumptions such as ingestion or topical application, catering to a wide range of medicinal and recreational uses.
  • Vaporizers: Recognizing the growing demand for smoke-free alternatives, Cronos Group offers high-quality cannabis vaporizers. These devices are designed for convenient and discreet use, providing a modern approach to cannabis consumption.
  • Edibles: Catering to the evolving tastes of their consumer base, Cronos Group has ventured into the world of cannabis-infused edibles. This range includes various ingestible forms, offering a delicious and controlled way to experience the effects of cannabis.
  • Cannabis Tinctures: For those preferring direct ingestion or alternative application methods, Cronos Group's cannabis tinctures offer a potent and precise dosing solution. These liquid extracts can be consumed directly or mixed with food or drinks, providing flexibility in usage.

The product lineup is marketed under distinguished brands such as Spinach, Lord Jones, and PEACE NATURALS, each carrying a unique identity and clientele focus, thus allowing Cronos Group to cater to a broad spectrum of consumer needs and preferences.

Contact Information

Address: 111 Peter Street
Phone: 14165040004